• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal & Metabolism
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality
      • Environment, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Collaboration the key to unlock new drugs
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Discovery

Collaboration the key to unlock new drugs

Florencia Pereyra Segal works with a global network of researchers to develop potential medicines.

Jun 08, 2015

Harnessing the combined expertise of a global network of researchers is critical to understanding neglected diseases and changing how they are treated, according to Florencia Pereyra Segal, a senior investigator at the Novartis Institutes for BioMedical Research (NIBR).

Pereyra Segal joined NIBR’s Translational Medicine group last year to develop experimental therapies for infectious diseases. Her move into industry came after more than a decade working as a physician at Brigham and Women’s Hospital and Massachusetts General Hospital and as a researcher at the Ragon Institute of MGH, MIT and Harvard, where she was engaged in work to find treatments and vaccines for HIV/AIDS. She had also been on the faculty of Harvard Medical School.

It’s very nice to be able to do that in an environment that actually rewards you for looking for somebody with an entirely different perspective on something… to develop a drug that’s going to change the lives of people..

The most striking aspect of working in Translational Medicine, says Pereyra Segal, is the extent to which she’s part of a global team effort. “When you think about the diseases we’re trying to solve here, they’re very big problems, very complex, and it’s highly unlikely a single individual will be able to solve those puzzles on his own,” she says. “It behooves us to work as a team and to really take the best of every single area of expertise.

NIBR has chosen to consolidate its translational medicine expertise in a single global network of more than 350 highly qualified physicians and scientists at sites in Switzerland, the US and China. This model facilitates the sharing of translational ideas and knowledge across disease areas. Also, because they work at the interface of basic research and clinical application, Translational Medicine specialists are involved in a rich variety of interactions with scientists elsewhere in NIBR, across the wider Novartis organization and beyond. They include biologists, chemists, biostatisticians, epidemiologists, drug metabolism and pharmacokinetics specialists, regulatory experts and scientists from biotechnology firms and academic centers.

No wonder that Pereyra Segal, even after many years spent at world-leading teaching hospitals and research institutes, says she has never before experienced such extensive collaboration.

Tags: 
Infectious Diseases, Novartis Institutes for BioMedical Research, Working at Novartis, Drug Development
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

A kidney patient is smiling at the camera
Discovery

New hope for treating inflammatory diseases of the kidney

2D rendering of kidneys
Discovery

Predictive analytics could bring medicines to patients faster

Discovery

Making Possible: Stepping toward a future with cell and gene therapy

You are here

  1. Home ›
  2. Stories ›
  3. Discovery

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.